A Post-Pandemic Surge in Pediatric Epstein–Barr Virus Infection: A Six-Year Single- Center Retrospective Study in China, 2019–2024

Viruses are ancient travelers, moving silently through human populations long before we had names for them. One of the most common travelers is the Epstein-Barr virus, a microscopic agent that lives in the saliva of nearly everyone. For most people, the first time they meet this virus is harmless, often passing without a single symptom, especially if it happens in early childhood. But if a person encounters it later, perhaps as a teenager or young adult, the virus can cause a sudden illness known as infectious mononucleosis, marked by a high fever, a sore throat, and swollen glands. Once the virus enters the body, it does not leave; it hides quietly inside our immune cells for the rest of our lives, occasionally waking up if the body's defenses weaken. While usually manageable, this virus is a significant part of pediatric medicine because it can trigger more serious complications, and understanding when and how it spreads helps doctors protect children.

For several years, the world operated under a set of strict rules to stop the spread of a different virus, the one causing the global pandemic. Schools closed, children stayed home, and people wore masks. These measures were incredibly effective at stopping many common respiratory illnesses, but they also changed the way children interacted with the world around them. When these restrictions finally lifted, doctors began to notice something unexpected: a sudden, sharp rise in infections that had been quiet for a long time. In a recent study, researchers in China set out to see if this pattern held true for the Epstein-Barr virus. They looked at six years of medical records from a single large children's hospital in Hebei, tracking every test done to see if a child's blood contained the virus. Their goal was simple: to understand how the pandemic years and the return to normal life had altered the spread of this ancient virus among children.

The researchers gathered data from over thirty thousand blood tests taken between 2019 and 2024. They divided this time into three distinct chapters: the years before the pandemic, the years when restrictions were in place, and the years after restrictions were lifted. What they found was a clear and steady climb in the number of children testing positive. Before the pandemic, about one in ten children tested showed signs of an active infection. During the pandemic years, that number rose slightly. But once the world opened up again, the rate jumped significantly, with nearly one in six children testing positive in the most recent years. This was not a temporary spike; the increase remained high throughout the two years following the end of strict measures, suggesting a fundamental shift in how the virus is moving through the population.

Along with the rise in numbers, the researchers noticed a change in who was getting sick. In the years before the pandemic, the virus was most commonly found in very young children, specifically those between the ages of one and six. This makes sense, as they are the ones who typically explore the world with their mouths and hands, sharing germs easily. However, in the years after the pandemic, the center of the outbreak moved upward. The virus began appearing much more frequently in school-aged children and even teenagers. The average age of a child with an active infection climbed steadily, shifting from toddlers to children old enough to be in elementary school. This suggests that many children who would have caught the virus as toddlers were protected by the lockdowns, only to encounter it later when they returned to classrooms and playgrounds, creating a large group of older children who were meeting the virus for the first time.

The study also looked at why these children were being tested in the first place. While the classic symptoms of a severe sore throat and swollen glands were still common, the researchers saw a notable rise in children being tested because they had pneumonia or infections of the upper airways. This indicates that the virus might be causing a broader range of symptoms in the post-pandemic era, or that it is spreading alongside other respiratory bugs that are also surging as children mix again. The data showed that girls were slightly more likely to test positive than boys, though the difference was small, and the risk of infection grew steadily as children got older, peaking in the preschool years before leveling off in adolescence.

Despite these clear trends, the researchers were careful to note what they could not prove. They could not say for certain whether the virus was waking up from its hiding place inside the body or if these were entirely new infections, as the blood test they used cannot distinguish between the two. They also acknowledged that the way they measured the virus changed slightly during the study, which might have influenced the exact numbers they saw for the intensity of the infection. Furthermore, because this was a study of just one hospital, they could not be sure if the same pattern was happening everywhere, though similar findings from another major city in China suggest this is a widespread phenomenon.

The story told by these numbers is one of delayed exposure. The pandemic acted as a pause button, keeping a large group of children away from the virus they would have normally encountered in their earliest years. When that pause ended, the virus did not just return; it surged into a population that was now older and perhaps less prepared for it. The virus found a new rhythm, moving more often into schoolyards than playgrounds and causing more respiratory issues than before. This research does not offer a cure or a new vaccine, but it provides a clear map of where the virus is going. It tells doctors and parents that the landscape of childhood illness has changed, and that watching for this virus in older children is now just as important as watching for it in toddlers. The virus is still the same, but the children it infects are different, and the timing of that infection has shifted in a way that will likely shape pediatric care for years to come.